Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...

Ivim Health raises concern over US FDA’s arbitrary critical deadline comes; submits Amicus brief to fighting patient access to GLP-1 medications: Columbus, Ohio Thursday, Februa ...

"Offering Zepbound single-dose vials […] through another platform to LillyDirect will help ensure broader availability of rigorously tested, FDA-approved, and regulated obesity treatment ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

The shortage, which began in December 2022 for Mounjaro and extended to Zepbound in April 2023 ... The restoration of Mounjaro’s availability coincides with increasing competition in the ...

Medical experts have long warned about alcohol's risks, and now the drinks industry is embracing sobriety, investing in ...

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Medical Center Hospital is celebrating 200 successful open-heart surgeries in 2024. The Beat Goes On will take place from 4 p ...

The Midland Health Drive Thru Testing Clinic saw 30 patients Feb. 7 with a 26% positivity rate. The clinic will be testing Feb. 8 from 9 a.m. to 1 p.m. In addition, the clinic will be open next week ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.